Ben AM. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol. 2006;105(1–2):1–25. https://doi.org/10.1016/j.jep.2006.02.001.
Mack A, Joy J. In: Marijuana as Medicine? The Science Beyond the Controversy. Washington (DC): National Academies Press (US) Copyright 2001 by the National Academy of Sciences. All rights reserved.; 2000.
Odieka AE, Obuzor GU, Oyedeji OO, Gondwe M, Hosu YS, Oyedeji AO. The Medicinal Natural Products of Cannabis sativa Linn.: A Review. Molecules. 2022;27(5); https://doi.org/10.3390/molecules27051689
The Global Cannabis Report. https://newfrontierdata.com/global-cannabis/ (2024). Accessed.
Medical Marijuana Market Size, Share & Trends Analysis Report By Product Type (Flower, Oil & Tinctures), By Application (Chronic Pain, Arthritis, Migraine, Cancer, Diabetes, AIDS, Epilepsy, Parkinson’s Disease), By Region, And Segment Forecasts, 2023 - 2030. https://www.grandviewresearch.com/industry-analysis/medical-marijuana-market (2024). Accessed.
Finn DP, Haroutounian S, Hohmann AG, Krane E, Soliman N, Rice ASC. Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies. Pain. 2021;162(Suppl 1):S5-s25. https://doi.org/10.1097/j.pain.0000000000002268.
Article CAS PubMed PubMed Central Google Scholar
Romero-Sandoval EA, Kolano AL, Alvarado-Vázquez PA. Cannabis and Cannabinoids for Chronic Pain. Curr Rheumatol Rep. 2017;19(11):67. https://doi.org/10.1007/s11926-017-0693-1.
Article CAS PubMed Google Scholar
Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344–64. https://doi.org/10.1111/j.1476-5381.2011.01238.x.
Article CAS PubMed PubMed Central Google Scholar
Study shows Cannabis terpenes provide pain relief, contribute to 'entourage effect'. https://www.sciencedaily.com/releases/2021/07/210714110455.htm (2021). Accessed
Fisher E, Moore RA, Fogarty AE, Finn DP, Finnerup NB, Gilron I, et al. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain. 2021;162(Suppl 1):S45-s66. https://doi.org/10.1097/j.pain.0000000000001929.
Article CAS PubMed Google Scholar
Di Marzo V, Piscitelli F. The Endocannabinoid System and its Modulation by Phytocannabinoids. Neurotherapeutics. 2015;12(4):692–8. https://doi.org/10.1007/s13311-015-0374-6.
Article CAS PubMed PubMed Central Google Scholar
Ratcliffe E, Sunil M, Podinic T, Kasinska J, Hirota J, Raha S. A200 EXPOSURE TO CANNABIS SMOKE IN UTERO AFFECTS THE DEVELOPMENT OF THE ENDOCANNABINOID SYSTEM IN THE GASTROINTESTINAL TRACT. J Canadian Assoc Gastroenterol. 2024;7(Supplement_1):157–8. https://doi.org/10.1093/jcag/gwad061.200.
Lu H-C, Mackie K. Review of the Endocannabinoid System. Biol Psychiatry: Cognitive Neuroscience Neuroimaging. 2021;6(6):607–15. https://doi.org/10.1016/j.bpsc.2020.07.016.
Murru E, Manca C, Carta G, Ruggiu M, Solinas R, Montisci R, et al. Indirect Calorimetry-Based Novel Approach for Evaluating Metabolic Flexibility and Its Association with Circulating Metabolic Markers in Middle-Aged Subjects. Nutrients. 2024;16(4):525.
Article CAS PubMed PubMed Central Google Scholar
Rutger SG, Mary BF, Kevin PB. Got the Munchies for an Egg Sandwich? The Effects of Cannabis on Bowel Motility and Beyond. Journal of Nuclear Medicine Technology. 2024:jnmt.123.266816; https://doi.org/10.2967/jnmt.123.266816
Hinz B, Ramer R. Cannabinoids as anticancer drugs: current status of preclinical research. Br J Cancer. 2022;127(1):1–13. https://doi.org/10.1038/s41416-022-01727-4.
Article CAS PubMed PubMed Central Google Scholar
Kienzl M, Hasenoehrl C, Maitz K, Sarsembayeva A, Taschler U, Valadez-Cosmes P, et al. Monoacylglycerol lipase deficiency in the tumor microenvironment slows tumor growth in non-small cell lung cancer. Oncoimmunology. 2021;10(1):1965319. https://doi.org/10.1080/2162402x.2021.1965319.
Article CAS PubMed PubMed Central Google Scholar
Qiu C, Yang L, Wang B, Cui L, Li C, Zhuo Y, et al. The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer. Biomed Pharmacother. 2019;115:108952. https://doi.org/10.1016/j.biopha.2019.108952.
Article CAS PubMed Google Scholar
Glodde N, Jakobs M, Bald T, Tüting T, Gaffal E. Differential role of cannabinoids in the pathogenesis of skin cancer. Life Sci. 2015;138:35–40. https://doi.org/10.1016/j.lfs.2015.04.003.
Article CAS PubMed Google Scholar
Xiang W, Shi R, Kang X, Zhang X, Chen P, Zhang L, et al. Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression. Nat Commun. 2018;9(1):2574. https://doi.org/10.1038/s41467-018-04999-8.
Article CAS PubMed PubMed Central Google Scholar
Gruber T, Robatel S, Kremenovic M, Bäriswyl L, Gertsch J, Schenk M. Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma. Cancers (Basel). 2021;13(8); https://doi.org/10.3390/cancers13081934
Zaiachuk M, Pryimak N, Kovalchuk O, Kovalchuk I. Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy. Front Med (Lausanne). 2021;8:713153. https://doi.org/10.3389/fmed.2021.713153.
Sarsembayeva A, Kienzl M, Gruden E, Ristic D, Maitz K, Valadez-Cosmes P, et al. Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8(+) T and NK cells. Front Immunol. 2022;13:997115. https://doi.org/10.3389/fimmu.2022.997115.
Article CAS PubMed Google Scholar
Laezza C, Pagano C, Navarra G, Pastorino O, Proto MC, Fiore D, et al. The Endocannabinoid System: A Target for Cancer Treatment. Int J Mol Sci. 2020;21(3); https://doi.org/10.3390/ijms21030747
Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921–5. https://doi.org/10.1016/j.cub.2020.06.081.
Article CAS PubMed PubMed Central Google Scholar
Sheik A, Farani MR, Kim E, Kim S, Gupta VK, Kumar K, et al. Therapeutic targeting of the tumor microenvironments with cannabinoids and their analogs: Update on clinical trials. Environ Res. 2023;231(Pt 1):115862. https://doi.org/10.1016/j.envres.2023.115862.
Article CAS PubMed Google Scholar
O’Brien K. Medicinal Cannabis: Issues of evidence. European Journal of Integrative Medicine. 2019;28:114–20. https://doi.org/10.1016/j.eujim.2019.05.009.
Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312(7023):71–2. https://doi.org/10.1136/bmj.312.7023.71.
Article CAS PubMed PubMed Central Google Scholar
Sallan SE, Zinberg NE, Frei E 3rd. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med. 1975;293(16):795–7. https://doi.org/10.1056/nejm197510162931603.
Article CAS PubMed Google Scholar
Kluin-Neleman JC, Neleman FA, Meuwissen OJ, Maes RA. delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo. Vet Hum Toxicol. 1979;21(5):338–40.
Zutt M, Hänssle H, Emmert S, Neumann C, Kretschmer L. Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases. Hautarzt. 2006;57(5):423–7. https://doi.org/10.1007/s00105-005-1063-x.
Article CAS PubMed Google Scholar
Meiri E, Jhangiani H, Vredenburgh JJ, Barbato LM, Carter FJ, Yang HM, et al. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Curr Med Res Opin. 2007;23(3):533–43. https://doi.org/10.1185/030079907x167525.
Article CAS PubMed Google Scholar
Duran M, Pérez E, Abanades S, Vidal X, Saura C, Majem M, et al. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br J Clin Pharmacol. 2010;70(5):656–63. https://doi.org/10.1111/j.1365-2125.2010.03743.x.
留言 (0)